MARKET

ALVO

ALVO

Alvotech
NASDAQ
4.580
-0.320
-6.53%
After Hours: 4.630 +0.05 +1.09% 19:07 01/06 EST
OPEN
4.815
PREV CLOSE
4.900
HIGH
4.900
LOW
4.400
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
13.70
52 WEEK LOW
4.320
MARKET CAP
1.43B
P/E (TTM)
21.89
1D
5D
1M
3M
1Y
5Y
1D
ATP Holdings Acquires Over 6.9 Million Alvotech Shares in Internal Dealings at SEK 44.06 Each
Reuters · 4h ago
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession
TipRanks · 6h ago
Transactions of Managers and Closely Associated Persons
Barchart · 10h ago
Alvotech announces CEO transition
Seeking Alpha · 10h ago
Alvotech Appoints Lisa Graver as CEO, Succeeding Chairman Robert Wessman
Dow Jones · 12h ago
Alvotech Appoints Lisa Graver As CEO, Rbert Wessman To Continue As Executive Chairman
NASDAQ · 12h ago
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed
TipRanks · 12h ago
Alvotech Appoints Lisa Graver as CEO as Róbert Wessman Becomes Full-Time Executive Chairman
Reuters · 12h ago
More
About ALVO
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.